Clinical Technologies Webinars

  1. How eConsent Improves Consent Development
    11/1/2016

    Developing informed consent content requires a lot of back and forth communication between multiple stakeholders - an inefficient, slow process with a history of allowing unapproved or out-of-date consents to be accidentally deployed to sites. Electronic Informed Consent (eConsent) offers a streamlined, collaborative process that promotes faster content development, approval and deployment on one platform, guaranteeing that only the most current and approved consent version is used each time.

  2. The Value Of Electronic Informed Consent
    11/1/2016

    Securing informed consent from clinical trial participants involves more than a signature—you need to ensure participants truly understand what they’re signing.  Learn from industry expert, Sandra “SAM” Sather, on how the electronic informed consent (eConsent) process improves the way participants are consented on a clinical trial.

  3. Reducing Regulatory Risk In Clinical Trials With eConsent
    11/1/2016

    You may already know too well the challenges of a paper-based Informed Consent process, but did you know that Informed Consent is one of the most cited deficiencies by regulatory authorities? Paper-based informed consent increases your risk for delayed approvals, fines, litigation and even trial failure.

  4. 3 Major Regulatory Risks You Can Reduce With Electronic Informed Consent
    11/1/2016

    You may already know too well the challenges of a paper-based Informed Consent process, but did you know that Informed Consent is one of the most cited deficiencies by regulatory authorities? Paper-based informed consent increases your risk for delayed approvals, fines, litigation and even trial failure.

  5. Recruiting And Retaining Patients With eConsent
    11/1/2016

    The informed consent process intends to ensure trial participants understand the risks and benefits of joining your trial, but a poor experience leads to low recruitment rates and costly drop-outs. Electronic Informed Consent (eConsent) improves recruitment and retention of participants by developing better comprehension of consent materials and improving engagement for the full duration of your study. In this short video, industry expert Sandra "Sam" Sather, reviews the ways that eConsent supports and adds value to the recruitment process.

  6. How To Calculate The True Cost Of Paper When Considering eCOA
    11/1/2016

    Clinical trials using electronic Clinical Outcome Assessments (eCOA) benefit from compliance rates 300% higher than paper-based studies - yet some sponsors hesitate to adopt eCOA due to a misconception that paper diaries cost less. We compare the often hidden costs of paper data collection vs. eCOA to help you decide which is best for your next trial.

  7. The Extinction Of Paper In Clinical Research
    10/14/2016

    Join adventurer and Data Manager Dr. Gooddata as he discovers the legend of the extinction of paper in clinical research.

  8. Put An End Paper-Based Data Collection In Clinical Research
    10/14/2016

    An unruly mob of protesters marches on Washington D.C., demanding an end to paper-based data collection in clinical research. Can President Gooddata and Chief of Staff Francois solve this global crisis?

  9. Switch From Paper To CFR Part 11 Compliant, CloudEDC™
    10/14/2016

    Watch as Dr. Gooddata makes the switch from paper data collection to mEDU, a CFR Part 11 compliant software with CloudEDC™ that is FREE for investigator initiated trials.

  10. Cloud EDC For Phase II, III, IV
    10/14/2016

    mCore is Medrio's all Phase eClinical suite which includes Cloud EDC™. It is well suited for Phase II, III, IV, in Pharma, Diagnostics, Medical Device, and Animal Health studies.